On July 29, 2026, TibaRay was featured on the iconic Nasdaq Tower in New York's Times Square, bringing our mission of "Curing Cancer in a FLASH™" to one of the world's most visible stages.
TibaRay was selected for this prestigious spotlight through Lehigh University's Startup Academy, an initiative that recognizes high-potential, innovative companies driving significant technological and commercial progress. Seeing our logo and mission illuminated over Times Square represents a powerful validation of the momentum behind our company and our dedication to transforming cancer care.
This global visibility reflects the growing realization that current cancer therapies must evolve. Standard radiotherapy remains slow and can cause significant damage to healthy surrounding tissues. TibaRay's breakthrough linear accelerator platform, the Galactica™, is designed to deliver high-precision radiation in a fraction of a second (milliseconds rather than minutes), effectively "freezing" tumor motion and sparing healthy tissue. You can read more about how this technology achieves ultra-high dose rates on our Technology page.
Beyond healthcare, this milestone highlights the versatile commercial potential of our core accelerator platform. While oncology is our primary mission, the same compact, high-efficiency linac technology is being developed to address major global markets, including industrial non-destructive testing (NDT) and high-throughput border security scanning. By addressing multiple sectors, TibaRay maximizes both its commercial opportunity and its global technological footprint. To learn more about our strategic commercial roadmap, visit our Markets page.
Thinh Tran
CEO, TibaRay, Inc.
TibaRay is a medical technology company developing next-generation FLASH radiotherapy systems to improve cancer treatment outcomes worldwide.
